Science

Mihaela Stana: The spectrum of adverse events during mBC treatment with ADCs

Mihaela Stana/LinkedIn

Feb 20, 2025, 09:40

Mihaela Stana: The spectrum of adverse events during mBC treatment with ADCs

Mihaela Stana, Oncology Specialist at Elysee Hospital, shared a post on LinkedIn about a paper she co-authored with colleagues published in European Journal of Clinical Oncology:

“Biggest thanks to Matteo Lambertini and the team Marta Perachino, Luca Arecco, Eva Blondeaux, Kristina Janković, Elene Mariamidze for our new article which approaches the spectrum of adverse events during metastatic breast cancer treatment with ADCs and their impact on QoL.

To check the complete results, you can access the paper.”

“Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis”

Authors: Matteo Lambertini, Mihaela Stana, Marta Perachino, Luca Arecco, Eva Blondeaux, Kristina Janković, Elene Mariamidze et al.

Mihaela Stana: The spectrum of adverse events during mBC treatment with ADCs

cancer Elene Mariamidze Eva Blondeaux Kristina Jankovic Luca Arecco Marta Perachino Matteo Lambertini metastatic breast cancer Mihaela Stana OncoDaily Oncology

Hagop Kantarjian: Advances and Revolution in Adult ALL Therapy Over the Last Decade

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Top 10 Immunotherapy Fellowships and Grants to Watch in 2025

July Is Sarcoma Awareness Month: What You Need to Know

Pat Soon-Shiong: SARS-CoV-2 Infection Can Awaken Sleeping Cancer Cells